These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28131741)

  • 41. Efficient virtual screening using multiple protein conformations described as negative images of the ligand-binding site.
    Virtanen SI; Pentikäinen OT
    J Chem Inf Model; 2010 Jun; 50(6):1005-11. PubMed ID: 20504004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 3,5-T2 is an alternative ligand for the thyroid hormone receptor β1.
    Mendoza A; Navarrete-Ramírez P; Hernández-Puga G; Villalobos P; Holzer G; Renaud JP; Laudet V; Orozco A
    Endocrinology; 2013 Aug; 154(8):2948-58. PubMed ID: 23736295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural classification of steroid-binding sites on proteins by coarse-grained atomic environment and its correlation with their biological function.
    Hori-Tanaka Y; Yura K; Takai-Igarashi T; Tanaka H
    Steroids; 2015 Apr; 96():81-8. PubMed ID: 25645710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nongenomic signaling pathways triggered by thyroid hormones and their metabolite 3-iodothyronamine on the cardiovascular system.
    Axelband F; Dias J; Ferrão FM; Einicker-Lamas M
    J Cell Physiol; 2011 Jan; 226(1):21-8. PubMed ID: 20658515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alternate pathways of thyroid hormone metabolism.
    Wu SY; Green WL; Huang WS; Hays MT; Chopra IJ
    Thyroid; 2005 Aug; 15(8):943-58. PubMed ID: 16131336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polypharmacology rescored: protein-ligand interaction profiles for remote binding site similarity assessment.
    Salentin S; Haupt VJ; Daminelli S; Schroeder M
    Prog Biophys Mol Biol; 2014; 116(2-3):174-86. PubMed ID: 24923864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of thyroid system-disrupting chemicals using in vitro and in vivo screening assays in Xenopus laevis.
    Sugiyama S; Shimada N; Miyoshi H; Yamauchi K
    Toxicol Sci; 2005 Dec; 88(2):367-74. PubMed ID: 16179385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting target-ligand interactions using protein ligand-binding site and ligand substructures.
    Wang C; Liu J; Luo F; Deng Z; Hu QN
    BMC Syst Biol; 2015; 9 Suppl 1(Suppl 1):S2. PubMed ID: 25707321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of site-directed spin labeling for characterizing protein-ligand complexes using simulated restraints.
    Constantine KL
    Biophys J; 2001 Sep; 81(3):1275-84. PubMed ID: 11509344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deiodination of thyroid hormones by iodothyronine deiodinase mimics: does an increase in the reactivity alter the regioselectivity?
    Manna D; Mugesh G
    J Am Chem Soc; 2011 Jul; 133(26):9980-3. PubMed ID: 21648483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability.
    Hennemann G; Docter R; Friesema EC; de Jong M; Krenning EP; Visser TJ
    Endocr Rev; 2001 Aug; 22(4):451-76. PubMed ID: 11493579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
    Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
    J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fold independent structural comparisons of protein-ligand binding sites for exploring functional relationships.
    Gold ND; Jackson RM
    J Mol Biol; 2006 Feb; 355(5):1112-24. PubMed ID: 16359705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Structure and function of thyroid hormone receptors].
    Antoniak GL; Ignatenko IuV; Babich NO; Snitinskii VV
    Tsitol Genet; 2000; 34(5):67-80. PubMed ID: 11213634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular dynamics simulations reveal multiple pathways of ligand dissociation from thyroid hormone receptors.
    Martínez L; Sonoda MT; Webb P; Baxter JD; Skaf MS; Polikarpov I
    Biophys J; 2005 Sep; 89(3):2011-23. PubMed ID: 15980170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of protein activity with small-molecule-controlled inteins.
    Skretas G; Wood DW
    Protein Sci; 2005 Feb; 14(2):523-32. PubMed ID: 15632292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta.
    Hangeland JJ; Doweyko AM; Dejneka T; Friends TJ; Devasthale P; Mellström K; Sandberg J; Grynfarb M; Sack JS; Einspahr H; Färnegårdh M; Husman B; Ljunggren J; Koehler K; Sheppard C; Malm J; Ryono DE
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3549-53. PubMed ID: 15177471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure-based investigation on the binding interaction of hydroxylated polybrominated diphenyl ethers with thyroxine transport proteins.
    Cao J; Lin Y; Guo LH; Zhang AQ; Wei Y; Yang Y
    Toxicology; 2010 Nov; 277(1-3):20-8. PubMed ID: 20804816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure-Based Virtual Screening Protocol for in Silico Identification of Potential Thyroid Disrupting Chemicals Targeting Transthyretin.
    Zhang J; Begum A; Brännström K; Grundström C; Iakovleva I; Olofsson A; Sauer-Eriksson AE; Andersson PL
    Environ Sci Technol; 2016 Nov; 50(21):11984-11993. PubMed ID: 27668830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Thyroid hormones and their precursors I. Biochemical properties].
    Tóth G; Noszál B
    Acta Pharm Hung; 2013; 83(2):35-45. PubMed ID: 23926648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.